Smoking Does Not Affect Outcomes of Immunotherapy-Based mRCC Treatments
Unlike some other cancers, smoking status was not predictive in mRCC treated with first-line immunotherapy combinations.
United States University Of Utah Salt Lake City Georges Gebrael International Metastatic Renal Cell Carcinoma Database Consortium Huntsman Cancer Institute
Source: renalandurologynews.com